Paliperidone N oxide impurity is a degradation byproduct arising from the oxidation of a tertiary amine in the parent antipsychotic drug paliperidone. It features an N-oxide functional group at the piperidine ring, retaining the core aromatic piperidine-butyrophenone scaffold with a 4-fluorophenyl substitution. The compound exhibits a zwitterionic character due to the polar N-oxide and adjacent amide moieties, which influence its solubility and chromatographic behavior. Structurally, it differs from paliperidone by the absence of the hydroxyl group at the piperidine nitrogen, replaced by an oxygen atom. This impurity is specifically employed as an HPLC reference standard for quantifying oxidative degradation pathways in paliperidone formulations.
On Request1200448-52-7
| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1491842 โ | 20 mg | USD 863.00 |
CC1=C(C(=O)N2CCCC(C2=N1)O)CC[N+]3(CCC(CC3)C4=NOC5=C4C=CC(=C5)F)[O-]
InChI=1S/C23H27FN4O4/c1-14-17(23(30)27-9-2-3-19(29)22(27)25-14)8-12-28(31)10-6-15(7-11-28)21-18-5-4-16(24)13-20(18)32-26-21/h4-5,13,15,19,29H,2-3,6-12H2,1H3
SOGHBNZGNKDZHD-UHFFFAOYSA-N